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Although Lacosamide (LCM) has become a widely used drug in
patients with status epilepticus,1 the role of LCM in patients with
idiopathic generalized epilepsy presenting with absence status
epilepticus (ASE) is currently unknown.
A 57-year-old woman came to be under our observation after
experiencing confusion and drowsiness, immediately after
waking up. Her family history was unremarkable. Apart from
mild mental retardation and epilepsy, she had no other medical
problems. Rare tonic-clonic seizures, and episodes of lost contact
lasting for a few seconds or minutes had occurred monthly since
the age of 6 years old despite having been treated with 2000 mg/
day valproate (VPA), 300 mg/day lamotrigine (LTG), 3000 mg/day
levetiracetam (LEV), 300 mg/day topiramate, 100 mg/day phe-
nobarbital. The interictal EEG showed generalized spike-wave
and polyspike-wave discharges at 3–4 Hz, lasting from 1 to 3 s.
Brain MRI and genetic analysis (karyotype and array-CGH) were
normal. After 6 h from the onset of confusion, the patient was
admitted to our centre and at that time she was on 2000 mg/day
VPA (plasma VPA was 87 mg/L, range 50–100 mg/L) and
3000 mg/day LEV (plasma LEV was 25 mg/L, range 10–37 mg/
L). A long-term video-EEG monitoring was performed and ASE
was diagnosed. In particular, she was slow, vague, inattentive,
with no verbal contact and displayed rare, small myoclonic
twitches of the eyelids and facial muscles. The ictal EEG revealed
a continuous, generalized, 2.5–4 Hz spike, polispike-wave
pattern and brief trains of polispikes during confusional state
(Fig. 1a). Intravenous (IV) diazepam (10 mg in bolus) induced a* Corresponding author. Tel.: +39 0881/736125; fax: +39 0881/732553.
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5 min. The administration of IV diazepam (10 mg bolus) was also
repeated without effect. We therefore administered an IV loading
dose of 200 mg LCM over a period of 15 min, through a peripheral
line, diluted in 50 ml of normal saline. During and at the end of
infusion, the clinical picture and EEG pattern were unchanged
(Fig. 1c). After 10 min, an additional 200 mg of LCM was
administered for 15 min without effect (Fig. 1d). No adverse
effects were observed during the administration of LCM and no
ECG and laboratory values-changes were documented. After 24 h
the ASE spontaneously resolved. The patient was then given
2000 mg/day VPA and 100 mg/day LTG, while LEV was gradually
discontinued. She has now been seizure-free during the 12
months of follow-up.
Although the most commonly used bolus dose of LCM is 200–
400 mg over 3–5 min,1 the right dose and the infusion rate
needs further clariﬁcation. We tried splitting the dose of LCM
into two slow infusions of 200 mg to further evaluate the
efﬁcacy. Status epilepticus is considered aborted if ictal patterns
cease within 20 min following treatment and remains sup-
pressed for 40 min.2 Therefore, it is evident that LCM was not
effective in our case.
ASE is a form of non-convulsive status epilepticus character-
ized by ongoing or intermittent epileptic activity with beha-
vioural and cognitive changes and occurs in idiopathic
generalized epilepsy.3 ASE has also been evident in adults whose
idiopathic generalized epilepsy persists into adulthood and can
occur as a consequence of drug withdrawal or other external
factors such as sleep deprivation, excessive alcohol intake,
menstruation, fever and metabolic disturbances. Finally, inap-
propriate antiepileptic drugs (especially carbamazepine) can also
result in typical or atypical ASE. The EEG demonstrates a pattern of
prolonged generalized synchronous 3 Hz spike-wave complexes;
however, if ASE continues for several hours or more, the frequency
of spike-wave discharges decreases. Variable response of ASE
occurs with IV benzodiazepines, while good control with
adequate doses of anti-absence drugs, mainly VPA, has been
documented. The mechanism underlying the generation of
absence seizures is due to an oscillatory activity within a
corticothalamic network that depends on GABAergic systems,
but especially T-type calcium channels.4 Phenytoin (PHT) and
carbamazepine (CBZ) inhibit voltage-gated sodium channels
(VGSCs) at therapeutic concentrations and the attenuation of
Na+ current is the main mechanism of their efﬁcacy for thevier Ltd. All rights reserved.
Fig. 1. Generalized polispike-and-wave pattern during patient’s confusional state (a). IV diazepam induced a transient effect (b), while IV LCM was not effective (c and d).
G. d’Orsi et al. / Seizure 23 (2014) 397–398398treatment of focal and generalized tonic–clonic seizures, but not
against absence seizures. In fact, these drugs are ineffective in
pentetrazol-treated rodents, a model used to identify drugs that
are efﬁcacious for absence seizures. LCM acts primarily by
interfering with the slowly inactivating component of voltage-
gated sodium currents, without affecting the fast component that
is targeted by traditional sodium channel blockers.1 Moreover, as
with PHT and CBZ, previous experimental evidence in rodent
models showed that LCM did not provide protection against
seizures provoked by pentylenetetrazol,4 and no effect is observed
on voltage-clamped Ca2+ channels (T-, L-, N- or P-type). Consistent
with this data, our case conﬁrms that LCM selectively targets
VGSCs, showing efﬁcacy for the treatment of focal and generalized
tonic-clonic seizures, but not against absence seizures and ASE.Conﬂicts of interest
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